Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 71

1.

[Depressive affect and surrogate markers in HIV infected patients].

Brauchli P, Zeier H.

Psychother Psychosom Med Psychol. 1997 Jan;47(1):34-40. German.

PMID:
9139325
2.

Depression and HIV infection: impact on immune function and disease progression.

Cruess DG, Petitto JM, Leserman J, Douglas SD, Gettes DR, Ten Have TR, Evans DL.

CNS Spectr. 2003 Jan;8(1):52-8. Review.

PMID:
12627049
3.

Optimistic explanatory style and dispositional optimism in HIV-infected men.

Tomakowsky J, Lumley MA, Markowitz N, Frank C.

J Psychosom Res. 2001 Oct;51(4):577-87.

PMID:
11595246
4.

Low blood CD8+ T-lymphocytes and high circulating monocytes are predictors of HIV-1-associated progressive encephalopathy in children.

Sánchez-Ramón S, Bellón JM, Resino S, Cantó-Nogués C, Gurbindo D, Ramos JT, Muñoz-Fernández MA.

Pediatrics. 2003 Feb;111(2):E168-75.

PMID:
12563091
5.

Quality of life and immune activation in patients with HIV-infection.

Schroecksnadel K, Sarcletti M, Winkler C, Mumelter B, Weiss G, Fuchs D, Kemmler G, Zangerle R.

Brain Behav Immun. 2008 Aug;22(6):881-9. doi: 10.1016/j.bbi.2007.12.011. Epub 2008 Feb 7.

PMID:
18261883
6.

The reference range of CD4+ and CD8+ T-lymphocytes in healthy non-infected infants born to HIV-1 seropositive mothers; a preliminary study at Siriraj Hospital.

Likanonsakul S, Wasi C, Thepthai C, Sutthent R, Louisirirotchanakul S, Chearskul S, Vanprapa N, Lebnark T.

Southeast Asian J Trop Med Public Health. 1998 Sep;29(3):453-63.

PMID:
10437939
7.

Oral candidiasis as a clinical marker related to viral load, CD4 lymphocyte count and CD4 lymphocyte percentage in HIV-infected patients.

Campo J, Del Romero J, Castilla J, García S, Rodríguez C, Bascones A.

J Oral Pathol Med. 2002 Jan;31(1):5-10.

PMID:
11896816
8.

Differential upregulation of CD38 on different T-cell subsets may influence the ability to reconstitute CD4+ T cells under successful highly active antiretroviral therapy.

Benito JM, López M, Lozano S, Ballesteros C, Martinez P, González-Lahoz J, Soriano V.

J Acquir Immune Defic Syndr. 2005 Apr 1;38(4):373-81.

PMID:
15764953
9.

A randomized study comparing triple versus double antiretroviral therapy or no treatment in HIV-1-infected patients in very early stage disease: the Spanish Earth-1 study.

García F, Romeu J, Grau I, Sambeat MA, Dalmau D, Knobel H, Gomez-Sirvent JL, Arrizabalaga J, Cruceta A, Clotet BG, Podzamczer D, Pumarola T, Gallart T, O'Brien WA, Miró JM, Gatell JM.

AIDS. 1999 Dec 3;13(17):2377-88.

PMID:
10597779
10.

The rate of serious bacterial infections among HIV-infected children with immune reconstitution who have discontinued opportunistic infection prophylaxis.

Nachman S, Gona P, Dankner W, Weinberg A, Yogev R, Gershon A, Rathore M, Read JS, Huang S, Elgie C, Hudgens K, Hughes W.

Pediatrics. 2005 Apr;115(4):e488-94. Epub 2005 Mar 16.

PMID:
15772172
11.

Residual viraemia in HIV-1-infected patients with plasma viral load <or=20 copies/ml is associated with increased blood levels of soluble immune activation markers.

Ostrowski SR, Katzenstein TL, Pedersen BK, Gerstoft J, Ullum H.

Scand J Immunol. 2008 Dec;68(6):652-60. doi: 10.1111/j.1365-3083.2008.02184.x.

12.

Fatigue in HIV illness: relationship to depression, physical limitations, and disability.

Ferrando S, Evans S, Goggin K, Sewell M, Fishman B, Rabkin J.

Psychosom Med. 1998 Nov-Dec;60(6):759-64.

PMID:
9847037
13.

[T-lymphocyte immune in HIV-infected people and AIDS patients in China].

Li T, Qiu Z, Wang A, Sheng R.

Zhonghua Yi Xue Za Zhi. 2002 Oct 25;82(20):1391-5. Chinese.

PMID:
12509921
14.

Depression and CD4 cell count among persons with HIV infection in Uganda.

Kaharuza FM, Bunnell R, Moss S, Purcell DW, Bikaako-Kajura W, Wamai N, Downing R, Solberg P, Coutinho A, Mermin J.

AIDS Behav. 2006 Jul;10(4 Suppl):S105-11.

PMID:
16802195
15.

Immune responses to measles immunization and the impacts on HIV-infected children.

Thaithumyanon P, Punnahitananda S, Thisyakorn U, Praisuwanna P, Ruxrungtham K.

Southeast Asian J Trop Med Public Health. 2000 Dec;31(4):658-62.

PMID:
11414407
16.
18.

Stress and depressive symptoms prospectively predict immune change among HIV-seropositive men. HIV Neurobehavioral Research Center Group.

Patterson TL, Semple SJ, Temoshok LR, Atkinson JH, McCutchan JA, Straits-Tröster K, Chandler JL, Grant I.

Psychiatry. 1995 Nov;58(4):299-312.

PMID:
8746489
19.

Daily low-dose subcutaneous interleukin-2 added to single- or dual-nucleoside therapy in HIV infection does not protect against CD4+ T-cell decline or improve other indices of immune function: results of a randomized controlled clinical trial (ACTG 248).

Vogler MA, Teppler H, Gelman R, Valentine F, Lederman MM, Pomerantz RJ, Pollard RB, Cherng DW, Gonzalez CJ, Squires KE, Frank I, Mildvan D, Mahon LF, Schock B; AIDS Clinical Trials Group 248 Study Team..

J Acquir Immune Defic Syndr. 2004 May 1;36(1):576-87.

PMID:
15097300

Supplemental Content

Support Center